abstract |
FIELD: biotechnologies. n SUBSTANCE: invention pertains to the versions of antibodies against IL-6 receptor, variable regions of light and heavy chains of which are modified by introduction of amino-acid replacement. There revealed is a pharmaceutical composition for treating the diseases associated with IL-6 and containing the said version of antibody. n EFFECT: invention allows efficient treatment of the diseases associated with IL-6. n 8 cl, 48 dwg, 16 tbl, 20 ex |